Galixir, founded in 2019, is dedicated to employing cutting-edge artificial intelligence (AI) technologies to accelerate drug research and development. By leveraging its AI algorithms and organically integrating computational chemistry and medicinal chemistry, Galixir optimizes preclinical R&D processes by providing high-quality drug candidates and cutting time and costs. This increases the overall probability of product launch. Collaborating with pharmaceutical companies and institutions globally, Galixir is advancing its drug discovery pipelines for multiple indications, and new drug candidates designed and screened by different modules of PyxirTM, the proprietary AIDD platform at Galixir, are proved to have high potency, surpassed the level of existing drugs while ensuring patentability.
Company Details
- Employees
- 22
- Founded
- -
- Address
- Beijing, Cn
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.galixir.com
- HQ
- Beijing
Galixir Questions
Galixir's website is https://www.galixir.com
Galixir's LinkedIn profile is https://cn.linkedin.com/company/galixir
Galixir has
22 employees.
View email and phone details for 22
employees at Galixir.
Galixir's industry is
Biotechnology Research
Galixir's top competitors are
深度智耀 Dip,
Tandemai,
Clearstate,
Aureka Biotechnologies, Inc.,
Verkada,
Economist Intelligence: Eiu,
饕餮互动,
Aimble,
Helixon Us Inc.,
Inari.
Galixir's categories are Biotechnology Research
Galixir's founding year is 2019
